This site is intended for healthcare professionals

From Medscape Neurology

Coverage from the

Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024

September 18 - 20, 2024; Copenhagen, Denmark

September 18 - 20, 2024 Copenhagen, Denmark

Conference News

ECTRIMS 2024 sNFl and sGFAP Predict MS Disability in Unique Ways
MDedge News, October 7, 2024
ECTRIMS 2024 Time to Revisit the Treatment Approach in Kids With MS?
Medscape Medical News, September 30, 2024
ECTRIMS 2024 Undertreatment of Women With MS Unjustified
Medscape Medical News, September 27, 2024

1
ECTRIMS 2024 Ofatumumab MS Study Supports Early Start Over Switch
MDedge News, September 26, 2024
ECTRIMS 2024 Genetic Depression Tied to Increased MS Disease Activity
Medscape Medical News, September 25, 2024
ECTRIMS 2024 Disability Reduction Is a Twist in Negative BTKi RRMS Trial
MDedge News, September 24, 2024

ECTRIMS 2024 Comorbidity Control Might Slow MS Activity
MDedge News, September 23, 2024
ECTRIMS 2024 Positive Stem Cell Transplant Data Are Increasing Its Use
MDedge News, September 23, 2024
ECTRIMS 2024 Novel Agent First to Slow Disability in nrSPMS
Medscape Medical News, September 20, 2024
ECTRIMS 2024 McDonald Criteria Update Aims to Simplify, Speed MS Diagnosis
Medscape Medical News, September 20, 2024
ECTRIMS 2024 High-Dose Vitamin D Linked to Lower Disease Activity in CIS
Medscape Medical News, September 20, 2024

28

Medscape Neurology©

Perspectives

Multiple Sclerosis Highlights From ECTRIMS 2024
Patricia K. Coyle, MD

Popular News From ECTRIMS/ACTRIMS 2023

'Frame Running' May Help Boost Physical Activity in MS People with multiple sclerosis and moderate-to-severe walking disability could engage in physical activity and improve their physical function with an adapted running frame, suggests new research.
Medscape Medical News, Oct 23, 2023
Subcutaneous Ocrelizumab, Ofatumumab 'Reassuring' in MS Anti-CD20 antibody therapy can be effectively and safely administered subcutaneously to patients with MS, even when switching from a prior treatment, two clinical trials suggest.
Medscape Medical News, Oct 25, 2023
Epstein-Barr and MS: Just How Strong Is the Link? Epstein-Barr virus, which affects about 95% of humans and causes mononucleosis, was viewed as cancer-causing, but evidence now shows that EBV has a pivotal role in MS development.
Medscape Medical News, Oct 26, 2023

Previous Coverage

Related Resources

Multiple Sclerosis

All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.